1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Endothelial Dysfunction Global Clinical Trials Review, H2, 2014

Endothelial Dysfunction Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Endothelial Dysfunction Global Clinical Trials Review, H2, 2014" provides data on the Endothelial Dysfunction clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Endothelial Dysfunction. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Endothelial Dysfunction. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Endothelial Dysfunction Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Endothelial Dysfunction 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Endothelial Dysfunction to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Endothelial Dysfunction to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Endothelial Dysfunction 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Endothelial Dysfunction Therapeutics Clinical Trials 30
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Takeda Pharmaceutical Company Limited 33
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 33
Pfizer Inc. 34
Clinical Trial Overview of Pfizer Inc. 34
Novartis AG 35
Clinical Trial Overview of Novartis AG 35
GlaxoSmithKline plc 36
Clinical Trial Overview of GlaxoSmithKline plc 36
Nestle S.A. 37
Clinical Trial Overview of Nestle S.A. 37
BioMarin Pharmaceutical Inc. 38
Clinical Trial Overview of BioMarin Pharmaceutical Inc. 38
Han Wha Pharma Co., Ltd. 39
Clinical Trial Overview of Han Wha Pharma Co., Ltd. 39
C. H. Boehringer Sohn AG and Co. KG 40
Clinical Trial Overview of C. H. Boehringer Sohn AG and Co. KG 40
Clinical Trial Overview of Top Institutes / Government 41
National Defense Medical College 41
Clinical Trial Overview of National Defense Medical College 41
Radboud University 42
Clinical Trial Overview of Radboud University 42
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences 43
Clinical Trial Overview of Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences 43
University of California, San Francisco 44
Clinical Trial Overview of University of California, San Francisco 44
Boston University 45
Clinical Trial Overview of Boston University 45
Emory University 46
Clinical Trial Overview of Emory University 46
Mayo Clinic 47
Clinical Trial Overview of Mayo Clinic 47
Wageningen University 48
Clinical Trial Overview of Wageningen University 48
Vanderbilt University 49
Clinical Trial Overview of Vanderbilt University 49
Wuhan General Hospital of Guangzhou Military Command 50
Clinical Trial Overview of Wuhan General Hospital of Guangzhou Military Command 50
Five Key Clinical Profiles 51
Appendix 74
Abbreviations 74
Definitions 74
Research Methodology 75
Secondary Research 75
About GlobalData 76
Contact Us 76
Disclaimer 76
Source 76

List of Tables
Endothelial Dysfunction Therapeutics, Global, Clinical Trials by Region, 2014* 7
Endothelial Dysfunction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Endothelial Dysfunction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Endothelial Dysfunction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Endothelial Dysfunction Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Endothelial Dysfunction Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Endothelial Dysfunction Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Endothelial Dysfunction Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Endothelial Dysfunction to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Endothelial Dysfunction Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Endothelial Dysfunction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Endothelial Dysfunction to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Endothelial Dysfunction Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Endothelial Dysfunction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Endothelial Dysfunction Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Endothelial Dysfunction Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Endothelial Dysfunction Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Endothelial Dysfunction Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Endothelial Dysfunction Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Endothelial Dysfunction Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Endothelial Dysfunction Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Endothelial Dysfunction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Endothelial Dysfunction Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Endothelial Dysfunction Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Endothelial Dysfunction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Endothelial Dysfunction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014* 33
Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 34
Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 35
Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 36
Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Nestle S.A., 2014* 37
Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by BioMarin Pharmaceutical Inc., 2014* 38
Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Han Wha Pharma Co., Ltd., 2014* 39
Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG and Co. KG, 2014* 40
Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by National Defense Medical College, 2014* 41
Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2014* 42
Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2014* 43
Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014* 44
Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston University, 2014* 45
Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2014* 46
Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014* 47
Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Wageningen University, 2014* 48
Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2014* 49
Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Wuhan General Hospital of Guangzhou Military Command, 2014* 50

List of Figures
Endothelial Dysfunction Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Endothelial Dysfunction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Endothelial Dysfunction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Endothelial Dysfunction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Endothelial Dysfunction Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Endothelial Dysfunction Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Endothelial Dysfunction Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Endothelial Dysfunction Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Endothelial Dysfunction to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Endothelial Dysfunction Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Endothelial Dysfunction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Endothelial Dysfunction to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Endothelial Dysfunction Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Endothelial Dysfunction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Endothelial Dysfunction Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Endothelial Dysfunction Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Endothelial Dysfunction Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Endothelial Dysfunction Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Endothelial Dysfunction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Endothelial Dysfunction Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Endothelial Dysfunction Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Endothelial Dysfunction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Endothelial Dysfunction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 75

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.